Skip to main content
FDA alert: ‘Substantial’ hypocalcemia risk with denosumab use in dialysis patients
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA alert: ‘Substantial’ hypocalcemia risk with denosumab use in dialysis patients
User login
Username
Password
Reset your password
Specialty
Lead
score
Rheumatology
1
1
Family Medicine/Primary Care
0
0.8
Nephrology
0
0.6
Internal Medicine
0
0.7
Diabetes & Endocrinology
0
0.9
Concept
Lead
score
Hemodialysis
1
1
Dialysis
0
0.99
Hypocalcemia
0
0.98
Renal Disease
0
0.24
Calcium
0
0.17
Kidney
0
0.17
Osteoarthritis
0
0.17
Muscle Spasm
0
0.08
Adverse Effects
0
0.06
Blood
0
0.06
Hand
0
0.06
Heart
0
0.06
Lung
0
0.06
Muscle
0
0.06
Osteoporosis
0
0.06
Patient Safety
0
0.06
Pedal
0
0.06
Seizure
0
0.06
Vitamin
0
0.06
Edit Tags